Evidence map›Paper›PMID 30401006›Full record

ReviewThe British journal of nutrition2018

Energy restriction in renal protection.

Si-Yang Wang, Guang-Yan Cai, Xiang-Mei Chen

Open access · hybridAbstract readReview
In one paragraph

Review in The British journal of nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. NADH/NADBiomolecules · 2021
    Review
  13. Observational
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Guang-Yan Cai
Xiang-Mei Chen
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Energy restriction (ER) has been widely studied as a novel intervention, and its ability to prolong life has been fully demonstrated. For example, ER can significantly extend the lifespans of model flies, worms, rodents and other mammals. The role of ER in renal protection has also been elucidated. In preclinical studies, adjusting total energy intake or consumption of specific nutrients has prophylactic or therapeutic effects on ageing-related kidney disease and acute and chronic kidney injury. Amino acid restriction has gradually attracted attention. ER mimetics have also been studied in depth. The protective mechanisms of ER and ER mimetics for renal injury include increasing AMP-activated protein kinase and sirtuin type 1 (Sirt1) levels and autophagy and reducing mammalian target of rapamycin, inflammation and oxidative stress. However, the renal protective effect of ER has mostly been investigated in rodent models, and the role of ER in patients cannot be determined due to the lack of large randomised controlled trials. To protect the kidney, the mechanism of ER must be thoroughly researched, and more accurate diet or drug interventions need to be identified.

Indexed as

Caloric RestrictionAgingAnimalsAutophagyDietEnergy MetabolismFemaleHumansInflammationInsulinKidneyKidney DiseasesMaleMetforminModels, AnimalOxidative StressInsulinMetforminPhosphorusResveratrolSaltsSirolimusSIRT1 protein, humanSirtuin 1AgeingAKI acute kidney injuryAMPK AMP-activated protein kinaseCKD chronic kidney diseaseDN diabetic nephropathyEnergy restrictionER energy restrictionERM energy restriction mimeticsESRD end-stage renal diseaseHIF hypoxia-inducible factor 1InflammationKidney injurymTOR mammalian target of rapamycinOxidative stressPi inorganic phosphatePR protein restrictionROS reactive oxygen speciesSirt1 sirtuin type 1Sirtuin type 1: AutophagyTGF-β transforming growth factor-β

Identifiers

PMID30401006
PMCPMC6316363
OpenAlexW2900376194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.